Acetaminophen for analgesia following pyloromyotomy: does the route of administration make a difference?

Arvid Yung1, Arlyne Thung2, Joseph D Tobias3

  • 1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH, USA.

Insights

Intravenous (IV) and rectal acetaminophen show similar efficacy for postoperative pain management in infants undergoing laparoscopic pyloromyotomy. This study found no significant differences in pain scores or recovery times between the two administration methods for infant analgesia.

Area of Science:

  • Pediatric Surgery
  • Anesthesiology
  • Pharmacology

Background:

  • Opioid-sparing analgesia is crucial in infants undergoing pyloromyotomy due to risks like hypoventilation.
  • Rectal acetaminophen is common, but data on intravenous (IV) acetaminophen for this procedure are limited.

Purpose of the Study:

  • To compare the efficacy of IV versus rectal acetaminophen for postoperative pain relief in infants.
  • To evaluate analgesic needs and recovery metrics after laparoscopic pyloromyotomy.

Main Methods:

  • Retrospective review of 68 infants undergoing laparoscopic pyloromyotomy.
  • Comparison of IV and rectal acetaminophen administration for postoperative analgesia.
  • Assessment of pain scores, supplemental analgesic use, and recovery times.

Main Results:

  • No significant differences were observed in pain scores between IV and rectal acetaminophen groups.
  • Perioperative analgesic requirements, recovery unit stay, and hospital discharge times were comparable.
  • Oral feeding tolerance and postoperative complications did not differ between the groups.

Conclusions:

  • IV and rectal acetaminophen demonstrate equivalent clinical efficacy in infants undergoing laparoscopic pyloromyotomy.
  • Neither administration route offers a discernible advantage for postoperative analgesia in this patient population.
Abstract

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.1K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
625
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
1.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.4K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.5K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K